DOSSIER · 13F Holders · Q4 2025
4D MOLECULAR THERAPEUTICS IN
7 institutions still hold 4D MOLECULAR THERAPEUTICS IN as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 35104E104·7 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q4 2025
7 institutions reported 4D MOLECULAR THERAPEUTICS IN in Q4 2025. Novo Holdings A/S leads at 90.7% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.